Zentalis Pharmaceuticals, Inc.
USD3.72
-0.23 (-5.82%)
CEO
Julie Eastland
IPO Date
2020-04-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.86
Prev. Close
$3.95
Day Low
$3.62
Day High
$3.94
52W Low
$1.13
52W High
$6.95
Market Cap
$0.26B
Volume
1.15M
| 0 |
| $0.00 |
| 10 Feb 2026 | Bruns Ingmar | Chief Medical Officer | S-Sale | Disposed | 335 | $2.39 |
| 10 Feb 2026 | Bruns Ingmar | Chief Medical Officer | S-Sale | Disposed | 2,962 | $2.43 |
| 10 Feb 2026 | Vultaggio Vincent | PAO and PFO | S-Sale | Disposed | 29,951 | $2.43 |
| 10 Feb 2026 | Vultaggio Vincent | PAO and PFO | S-Sale | Disposed | 6,894 | $2.42 |
| 10 Feb 2026 | Vultaggio Vincent | PAO and PFO | S-Sale | Disposed | 3,379 | $2.39 |
| 10 Feb 2026 | EASTLAND JULIA MARIE | director, officer: CEO & President | S-Sale | Disposed | 889 | $2.39 |
| 10 Feb 2026 | EASTLAND JULIA MARIE | director, officer: CEO & President | S-Sale | Disposed | 7,866 | $2.43 |
| 4 Feb 2026 | Vultaggio Vincent | PAO and PFO | S-Sale | Disposed | 2,540 | $2.55 |